<h1>Centre of Excellence completes first autologous bone marrow transplant; patient improves - highlights informed consent, data protection, duty of care</h1> A hospital's Centre of Excellence for haemato-oncology completed its first autologous bone marrow transplant on a 61-year-old patient with multiple myeloma, resulting in discharge and clinical improvement. The report highlights institutional capacity, multidisciplinary staffing, advanced infection-control and post-transplant care. From a legal perspective, key points include documented therapeutic success reducing immediate malpractice exposure, potential regulatory compliance obligations for transplant centres, requirements for informed consent and post-operative follow-up, data-protection considerations for patient information, and ongoing duty of care. No allegations of negligence or litigation are reported; reputational and contractual implications for the healthcare provider and its corporate affiliate may follow.